Malignant Melanoma: Diagnostic and Management Update.

Area of Science:

• Oncology
• Dermatology
• Surgical Oncology

Background:

• Melanoma diagnosis and treatment have seen significant advancements.
• The American Joint Committee on Cancer Eighth Edition Staging System enhances patient risk stratification.
• Therapeutic options have evolved beyond surgery alone.

Purpose of the Study:

• To review recent advances in melanoma diagnosis, staging, and treatment.
• To highlight surgical innovations and their impact on patient outcomes.
• To discuss novel immunotherapies for advanced and metastatic melanoma.

Main Methods:

• Review of current literature on melanoma staging, diagnosis, and treatment.
• Emphasis on surgical techniques, including sentinel lymph node biopsy and margin selection.
• Analysis of emerging genetic, molecular, and histopathologic diagnostic tools.

Main Results:

• The AJCC Eighth Edition Melanoma Staging System has improved risk stratification and outcomes.
• Sentinel lymph node biopsy and optimized surgical margins are crucial for patient management.
• Novel immunotherapies have significantly improved survival in metastatic melanoma and high-risk adjuvant settings.

Conclusions:

• Melanoma management has shifted towards personalized treatment strategies.
• Advances in staging, surgery, and immunotherapy offer improved prognoses for melanoma patients.
• Continued research into genetic and molecular markers will further refine melanoma treatment.